https://www.selleckchem.com/pr....oducts/lenalidomide-
Moreover, biological assays were performed to determine the effect of genetic variations on response to chemotherapy. Results The patients carrying rs6484711 variant A allele suffered a poor response to epirubicin and docetaxel for NAC (OR = 0.37, 95% CI 0.18-0.74, P = 0.005) in combined stage. Moreover, expression quantitative trait loci (eQTL) analyses and luciferase reporter assays revealed that rs6484711 A allele significantly increased the expression of ABTB2. Subsequent biological assays illustrated that upregulation of
Like
Comment
Share
